↓ Skip to main content

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

Overview of attention for article published in Radiation Oncology, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma
Published in
Radiation Oncology, July 2022
DOI 10.1186/s13014-022-02073-8
Pubmed ID
Authors

Jing Lin, Qiaojuan Guo, Zengqing Guo, Tianzhu Lu, Gang Chen, Shaojun Lin, Mei Chen, Chuanben Chen, Jianping Lu, Jingfeng Zong, Lina Tang, Yu Chen, Jianji Pan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 14%
Lecturer 1 14%
Student > Master 1 14%
Unknown 4 57%
Readers by discipline Count As %
Environmental Science 1 14%
Pharmacology, Toxicology and Pharmaceutical Science 1 14%
Business, Management and Accounting 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2022.
All research outputs
#15,328,338
of 22,797,621 outputs
Outputs from Radiation Oncology
#1,041
of 2,054 outputs
Outputs of similar age
#238,700
of 434,070 outputs
Outputs of similar age from Radiation Oncology
#22
of 45 outputs
Altmetric has tracked 22,797,621 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,054 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,070 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.